nam/aidsmap, 12 April 2017 A meta-analysis of studies of brief interventions to reduce HIV risk behaviour in HIV-negative gay men has concluded that there is evidence that such techniques did have a significant impact on the behaviours they were designed to change. It also found evidence that the best way to conduct such interventions was face-to-face, i.e. not via the internet, telephone or...
The following article contains interactive in infographics illustrating Indigenous rates of STIs/BBVs, compared to the non-Indigenous population. The graphic can be adjusted to display chlamydia, syphilis, gonorrhoea, HIV & hepatitis B.
‘A national shame’: Spike in Indigenous STI rates prompts call for urgent action (scroll down for graphics)
AMA, 23 Mar 2017 Training for doctors in how to identify and treat patients who have undergone female genital mutilation (FGM) should be included in tertiary medical curricula, the AMA said today. Releasing the AMA’s Position Statement on Female Genital Mutilation 2017, AMA President, Dr Michael Gannon, said that while FGM is only practised in about 30 countries, and is illegal in Australia...
Australian Institute of Health and Welfare (AIHW), 19 April 2017 Nearly 6,500 women and girls were hospitalised due to assault in Australia in 2013–14, with the violence usually perpetrated by a partner or spouse, according to new analysis from the Australian Institute of Health and Welfare (AIHW). The data, available as part of a new series of fact sheets on selected injuries, shows that over...
SHINE SA, 18 April 2017 Our upcoming ReFRESH Forum is on how to use interpreters effectively. Interpreters play an important role in our multicultural society, especially in their contribution to appropriate delivery of health care services. An interpreter’s role is to act as a conduit, conveying information in an understandable format between parties who do not share a common language...
The Age, Published APRIL 2 2017 Doctors are on the cusp of launching the first new male contraceptive in more than a century. But rather than a Big Pharma lab, the breakthrough is emerging from a university start-up in the heart of rural India. Years of human trials on the injectable, sperm-zapping product are coming to an end, and researchers are preparing to submit it for regulatory approval...